Shares of Virpax Pharmaceuticals Inc. undefined rocketed for a second straight day on heavy volume, after the company announced an upbeat pre-investigational...
Shares of Virpax Pharmaceuticals Inc.
rocketed for a second straight day on heavy volume, after the company announced an upbeat pre-investigational new drug response from the Food and Drug Administration on its product to inhibit SARS-CoV-2 and the flu. The stock shot up 53.6% in morning trading, after soaring 265.5% on Tuesday, to mark a two-day gain of 461.4%. Trading volume was 28.0 million shares early Wednesday, after a record total of 165.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Former FDA chief on the case for a more independent agencyThe former head of the Food and Drug Administration says there is a strong case for restructuring the agency to shield it from outside pressure.
Consulte Mais informação »
Pfizer, BioNTech Seek FDA Clearance for Covid-19 BoosterPfizer and BioNTech began the formal process of seeking FDA clearance for a Covid-19 booster shot, submitting data showing a third vaccine dose generated higher levels of neutralizing antibodies against the original virus and its Beta and Delta variants
Consulte Mais informação »
Pfizer submits data to FDA for authorization of Covid vaccine booster shot for general populationPfizer and BioNTech said they have submitted early-stage clinical trial data to the FDA as part of their application seeking U.S. OK of a Covid booster shot.
Consulte Mais informação »
COVID-19 of the Future: Endemic and Mostly in Young Children?Based on experience with other beta coronaviruses and modeling, experts say SARS-CoV-2 could become endemic and spread more like the common cold.
Consulte Mais informação »
Biden administration to encourage boosters for most AmericansThe Biden administration will soon recommend that Americans get a coronavirus booster shot eight months after completing their initial vaccination
Consulte Mais informação »
Ohio’s vaccine lottery saved more than $60m in averted healthcare costsWith the average hospital bill of a covid-19 patient in an American ICU clocking in at $13,500 per day, Ohio’s lottery programme managed to avoid $66m in hospital charges
Consulte Mais informação »